NCT04415606View on ClinicalTrials.gov

QuikClot Control+ Hemostatic Dressing Use in Mild to Moderate Bleeding

NACompletedINTERVENTIONAL
Enrollment

266

Participants

Timeline

Start Date

June 11, 2020

Primary Completion Date

October 30, 2021

Study Completion Date

October 30, 2021

Conditions
Hemostasis
Interventions
DEVICE

QuikClot Control+

Non-absorbable, sterile, X-ray detectable non-woven dressing impregnated with kaolin.

Trial Locations (7)

15232

UPMC Pittsburgh, Pittsburgh

17104

UPMC Pinnacle, Harrisburg

30322

Emory, Atlanta

63110

Washington University, St Louis

68506

Bryan Heart, Lincoln

80045

University of Colorado Health, Aurora

83201

Portneuf Medical Center / Snake River Research PLCC, Pocatello

Sponsors

Lead Sponsor

Z-Medica
All Listed Sponsors
lead

Z-Medica

INDUSTRY

NCT04415606 - QuikClot Control+ Hemostatic Dressing Use in Mild to Moderate Bleeding | Biotech Hunter | Biotech Hunter